Proposition 29, the California Cancer Research Act, is a California ballot measure that was defeated by California voters at the statewide election on June 5, 2012. The measure would have placed a $1 excise on tobacco products into a protected fund to finance medical research on smoking-related illnesses, strengthen California’s smoking prevention and cessation programs, and enforce the state’s existing tobacco laws. The independent California Legislative Analyst's Office projected that the measure would have generated approximately $855 million in first year, declining slightly but predictably every year thereafter. The measure would have created a nine-member committee charged with administering direct revenues. This oversight committee was to be composed of cancer-research medical professionals, University of California Chancellors, and representatives of national disease advocacy groups. The measure restricted administration costs to no more than 2% of its direct tax revenues. The California Cancer Research Act was widely supported by cancer advocates, including cancer survivorLance Armstrong and the American Cancer Society.
Detail
How CCRA revenue would have been spent
According to the independent California Legislative Analyst's Office, revenue raised by the measure would have been spent as follows:
60% : Research of cancer and tobacco-related disease "for the purpose of grants and loans to support research into the prevention, early detection, treatments, complementary treatments and potential cures of lung cancer and other types of cancer, cardiovascular disease, emphysema and other tobacco related diseases, including but not limited to coronary heart disease, and chronic obstructive lung disease";
15% : Facilities and capital equipment for research "for the purposes of grants and loans to provide facilities, including but not limited to those building, building leases and capital equipment as may be found necessary and appropriate by the Committee, to further biomedical, epidemiological, behavioral, health services, and other research whose primary focus is to identify and refine promising prevention, early detection, treatments, complementary treatments, rehabilitation and potential cures of lung cancer and other types of cancer, cardiovascular disease, emphysema and other tobacco related diseases";
3% : Tobacco law enforcement "to support law enforcement efforts to reduce cigarette smuggling, tobacco tax evasion, and counterfeit tobacco products, to reduce illegal sales of tobacco products to minors, and to enforce legal settlement provisions and conduct law enforcement training and technical assistance activities for tobacco related statues".
No more than 2% : Administration.
Oversight
The measure would have created a 9-member governing committee charged with administering the fund. The California Cancer Research Act Oversight Committee was to be composed of:
3 University of California chancellors;
3 "selected from among Cancer Center Directors of National Cancer Institute designated cancer centers located within the State of California"
1 "affiliated with a California Academic Medical Center who is a practicing physician with expertise in the prevention, treatment or research of cardiovascular disease"
2 "selected from among California representatives of California or national disease advocacy groups whose focus is tobacco-related illness, at least one of whom shall be a person who has been treated for a tobacco related illness."
The California Secretary of State confirmed that The California Cancer Research Act had qualified for California’s next statewide ballot on August 24, 2010, after its supporting coalition submitted 633,453 voter signatures for verification in June 2010. To qualify, the measure required 433,971 signatures, or more.
